02/02/2026
🔬 Exciting News for the HS Community!
New research from our team is helping us better understand hidradenitis suppurativa at a deeper level, literally!
Dr. Pekarev and our clinical team just published a study looking at the bacteria found deep within HS lesions in patients with advanced (stage III) disease who needed surgery.
Why does this matter to you?
For years, most research focused only on bacteria on the skin's surface. This study looked deeper at the tissue that surgeons actually treat during surgery. What we found could help us choose better antibiotics for each patient based on their specific health conditions.
We discovered that certain bacterial patterns are associated with diabetes and recent steroid use, which means your medical history is important when planning your treatment.
This is the kind of research that drives better, more personalized care for HS patients. Every study brings us closer to understanding this complex condition and improving outcomes for our community.
💙 To everyone living with HS: Your courage inspires us to keep researching, learning, and advancing care.
Learn more about the study: https://pubmed.ncbi.nlm.nih.gov/41580621/
The subcutaneous microbiome in stage III HS remains poorly characterized due to the historical focus on surface lesions and non-surgical populations. Our findings highlight distinct microbial profiles within deep tissue that are influenced by comorbidities and steroid use. Plastic and reconstructive...
